STAT6 and the regulation of CD23 expression in B-chronic lymphocytic leukemia

Leukemia Research

Volumn 24, Issue 4, 2000, Pages 331-337

  Kneitz, C ^a   Goller, M ^a   Seggewiss, R ^a   Yaman, A ^a   Serfling, E ^b   Tony, H P ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

CD23; CLL; IL 4; Signal transduction; STAT6

Indexed keywords

CD23 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 4; PHORBOL 13 ACETATE 12 MYRISTATE; STAT6 PROTEIN; TRANSCRIPTION FACTOR;

ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CHRONIC LYMPHATIC LEUKEMIA; ELECTROPHORETIC MOBILITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

BIOLOGICAL TRANSPORT; CD40 LIGAND; DNA-BINDING PROTEINS; HUMANS; INTERLEUKIN-4; LEUKEMIA, B-CELL, CHRONIC; MEMBRANE GLYCOPROTEINS; RECEPTORS, IGE; STAT1 TRANSCRIPTION FACTOR; STAT6 TRANSCRIPTION FACTOR; TETRADECANOYLPHORBOL ACETATE; TRANS-ACTIVATORS;

EID: 0034003062     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(99)00191-5     Document Type: Article

References (28)

1. Dighiero G., Travede P., Chevret S., Fenaux P., Chastang C., Binet J.L. B-cell chronic leukemia: present status and future directions. Blood. 78:1991;1901.
2. Fournier S., Yang L.P., Delespesse G., Rubio M., Biron G., Sarfati M. The two CD23 isoforms display differential regulation in chronic lymphocytic leukemia. Br. J. Haematol. 89:1995;373.
3. Fournier S., Tran I.D., Suter U., Biron G., Delespesse G., Sarfati M. The in vivo expression of type b CD23 mRNA in B chronic leukemic cells is associated with an abnormally low CD23 upregulation by IL-4: comparison with their normal cellular counterparts. Leuk. Res. 15:1991;609.
4. Sarfati M., Fournier S., Christoffersen M., Biron G. Expression of CD23 antigen and its regulation by IL-4 in chronic lymphocytic leukemia. Leuk. Res. 14:1990;47.
5. Fournier S., Delespesse G., Rubio M., Biron G., Sarfati M. CD23 antigen regulation and signaling in chronic lymphocytic leukemia. J. Clin. Invest. 89:1992;1212.
6. Tony H.P., Brückner A., Wilhelm M. Differential signal requirement or upregulation of HLA-class-II molecules in lymphoma B cells. Hematol. Pathol. 7:1993;79.
7. DeFrance T., Aubry J.P., Rousset F., Vandervliet B., Bonnefoy J.Y., Arai N., Takebe Y., Yokota T., Lee F., Arai K., DeVries J., Banchereau J. Human recombinant IL-4 induces Fcε receptors (CD23) on normal B lymphocytes. J. Exp. Med. 165:1987;1459.
8. Leonard W.J., O'Shea J.J. Jaks and stats: biological implications. Ann. Rev. Immunol. 16:1998;293.
9. Takeda K., Kishimoto T., Akira S. STAT6: its role in interleukin-4 mediated biologic functions. J. Mol. Med. 7:1997;317.
10. Takeda K., Tanaka T., Shi W., Matsumoto M., Minami M., Kashiwamura S.I., Nakanishi K., Yoshida N., Kishimoto T., Akira S. Essential role of STAT 6 in IL-4 signaling. Nature. 380:1996;627.
11. Kamogawa Y., Lee H.J., Johnston J.A., McMahon M., O'Garra A., Arain N. A conditionally active form of STAT 6 can mimic certain effects of IL-4. J. Immunol. 161:1998;1074.
12. Yokota A., Kikutani H., Tanaka T., Sato R., Barsumian E.L., Suemura M., Kishimoto T. Two species of human Fce receptor II (FceRII/CD23): tissue specific and IL-4-specific regulation of gene expression. Cell. 55:1988;611.
13. Köhler I., Alliger P., Minty A., Caput D., Ferrara P., Höll-Neugebauer B., Rank G., Rieber E.P. Human interleukin-13 activates the interleukin-4-dependent transcription factor NF-IL4 sharing a DNA binding motif with an interferon-g-induced nuclear binding factor. FEBS Lett. 345:1994;187.
14. Gouilleux-Gruart V., Gouilleux F., Desaint C., Claisse J.F., Capiod J.C., Delobel J., Weber-Nordt R., Dusanter-Fourt I., Dreyfus F., Groner B., Prin L. STAT-related transcriptions factors are constitutively activated in peripheral blood cells from acute leukemia patients. Blood. 87:1996;1692.
15. Weber-Nordt R.M., Egen C., Wehinger J., Goilleux-Gruart V., Mertelsmann R., Finke J. Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and epstein-barr virus (EBV)-related lymphoma cell lines. Blood. 88:1996;809.
16. Schuh K., Avots A., Tony H.P., Serfling E., Kneitz C. Nuclear NF-ATp is a hallmark of unstimulated B cells from B-CLL patients. Leuk. Lymph. 23:1996;583.
17. Caligaris-Cappio F., Janossy G. Surface markers in chronic lymphocytic leukemias of B cell type. Sem. Hematol. 22:1985;1.
18. Kaplan ME, Clark C. An improved rosetting assay for detection of human T lymphocytes. J. Immunol. Meth. 1974;5:131.
19. Kneitz C., Goller M., Wilhelm M., Mehringer C., Wohlleben G., Schimpl A., Tony H.-P. Inhibition of T cell/B cell interaction by B-CLL cells. Leukemia. 13:1998;98.
20. Schreiber E., Matthias P., Müller M.M., Schaffner W. Rapid detection of octamer binding proteins with mini-extracts prepared from a small number of cells. Nucl. Acid Res. 17:1989;6419.
21. Köhler I., Rieber E.P. Allergy associated Iε and Fcε receptor 2 (CD23b) genes activated via binding of an interleukin-4 induced transcritption factor to a novel responsive element. Eur. J. Immunol. 23:1993;3066.
22. Tony H.P., Lehrnbecher T., Merz H., Sebald W., Wilhelm M. Regulation of IL-4 responsiveness in lymphoma B cells. Leuk. Res. 15:1991;911.
23. Luo H.Y., Hofstetter H., Banchereau J., Delespesse G. Cross-linking of CD23 antigen by its natural ligand (IgE) or by anti-CD23 antibody prevents B lymphocyte proliferation and differentiation. J. Immunol. 147:1991;2122.
24. Suter U., Texido G., Hofstetter H. Expression of human lymphocyte IgE receptor (Fc epsilon RII/CD23). Identification of the Fc epsilon RIIa promoter and its functional analysis in B lymphocytes. J. Immunol. 143:1989;3078.
25. Frank D.A., Mahajan S., Ritz J. B lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transcription (STAT) 1 and STAT 3 constitutively phosphorylated on serine residues. J. Clin. Invest. 100:1997;3140.
26. Tinell S.B., Jacobs-Helber S.M., Sterneck E., Sawyer S.T., Conrad D.H. STAT6, NF-κB and c/EBP in CD23 expression and IgE production. Int. Immunol. 10:1998;1529.
27. Dinkel A., Aicher W.K., Haas C., Zipfel P.E., Peter H.H., Eibel H. Transcription factor Egr-1 activity down-regulates Fas and CD23 expression in B cells. J. Immunol. 159:1997;2678.
28. Wen Z., Zhong Z., Darnell J.E.J. Maximal activation of transcription by STAT1 and STAT3 requires both tyrosine and serine phosphorylation. Cell. 82:1995;241.